Healthcare provider profile · identity verified

Matthew Koperwas, M.D.

Geriatric Medicine · PITTSBURGH, PA · NPI 1821478751

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	357	78
Eliquis	Apixaban	340	36
Sertraline Hcl	Sertraline Hcl	236	28
Levothyroxine Sodium	Levothyroxine Sodium	228	40
Gabapentin	Gabapentin	219	39
Warfarin Sodium	Warfarin Sodium	219	suppressed
Trazodone Hcl	Trazodone Hcl	203	32
Amlodipine Besylate	Amlodipine Besylate	196	34
Furosemide	Furosemide	163	37
Lisinopril	Lisinopril	152	23
Potassium Chloride	Potassium Chloride	127	26
Metoprolol Succinate	Metoprolol Succinate	122	20
Oxycodone Hcl	Oxycodone Hcl	121	19
Levetiracetam	Levetiracetam	116	14
Metoprolol Tartrate	Metoprolol Tartrate	107	29
Mirtazapine	Mirtazapine	106	19
Diclofenac Sodium	Diclofenac Sodium	105	14
Lactulose	Lactulose	100	suppressed
Carvedilol	Carvedilol	98	18
Clopidogrel	Clopidogrel Bisulfate	98	17
Escitalopram Oxalate	Escitalopram Oxalate	83	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	80	20
Famotidine	Famotidine	75	16
Pantoprazole Sodium	Pantoprazole Sodium	74	20
Omeprazole	Omeprazole	70	24
Tramadol Hcl	Tramadol Hcl	68	17
Duloxetine Hcl	Duloxetine Hcl	67	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	67	15
Jardiance	Empagliflozin	66	suppressed
Buspirone Hcl	Buspirone Hcl	64	suppressed
Losartan Potassium	Losartan Potassium	57	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	11
Clonazepam	Clonazepam	55	suppressed
Bumetanide	Bumetanide	54	12
Hydralazine Hcl	Hydralazine Hcl	54	11
Venlafaxine Hcl Er	Venlafaxine Hcl	51	suppressed
Memantine Hcl	Memantine Hcl	48	suppressed
Metformin Hcl	Metformin Hcl	47	14
Albuterol Sulfate Hfa	Albuterol Sulfate	45	15
Trulicity	Dulaglutide	45	suppressed
Baclofen	Baclofen	44	suppressed
Cephalexin	Cephalexin	44	20
Donepezil Hcl	Donepezil Hcl	44	suppressed
Amantadine	Amantadine Hcl	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	suppressed
Latanoprost	Latanoprost	37	suppressed
Myrbetriq	Mirabegron	37	suppressed
Olanzapine	Olanzapine	37	suppressed
Ssd	Silver Sulfadiazine	37	suppressed
Lorazepam	Lorazepam	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Xtampza Er	Oxycodone Myristate	35	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	34	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	34	suppressed
Ondansetron Odt	Ondansetron	34	19
Risperidone	Risperidone	34	suppressed
Atenolol	Atenolol	33	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	33	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Timolol Maleate	Timolol Maleate	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Folic Acid	Folic Acid	31	suppressed
Brilinta	Ticagrelor	30	suppressed
Prednisone	Prednisone	30	suppressed
Finasteride	Finasteride	29	suppressed
Movantik	Naloxegol Oxalate	29	suppressed
Nystatin	Nystatin	29	suppressed
Santyl	Collagenase Clostridium Hist.	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Midodrine Hcl	Midodrine Hcl	28	suppressed
Prazosin Hcl	Prazosin Hcl	28	suppressed
Ingrezza	Valbenazine Tosylate	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Xarelto	Rivaroxaban	26	suppressed
Albuterol Sulfate	Albuterol Sulfate	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Simvastatin	Simvastatin	25	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Phenytoin	Phenytoin	24	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	22	suppressed
Phenytek	Phenytoin Sodium Extended	22	suppressed
Ammonium Lactate	Ammonium Lactate	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Topiramate	Topiramate	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Ramelteon	Ramelteon	20	suppressed
Tiotropium Bromide	Tiotropium Bromide	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Mirabegron Er	Mirabegron	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Haloperidol	Haloperidol	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	suppressed
Benztropine Mesylate	Benztropine Mesylate	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	14	suppressed
Lacosamide	Lacosamide	14	suppressed
Lithium Carbonate	Lithium Carbonate	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Primidone	Primidone	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Insulin Lispro	Insulin Lispro	13	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	13	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	12	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Entacapone	Entacapone	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Veltassa	Patiromer Calcium Sorbitex	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error